Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+61.4%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
+61.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.2x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025138.28%
202469.07%
2023-20.95%
202232.88%
2021-10.93%
2020-5.38%
201987.39%
2018-93.07%
2017-51.16%
2016-38.15%